Detalhe da pesquisa
1.
CPL207280, a Novel G Protein-Coupled Receptor 40/Free Fatty Acid Receptor 1-Specific Agonist, Shows a Favorable Safety Profile and Exerts Antidiabetic Effects in Type 2 Diabetic Animals.
Mol Pharmacol
; 100(4): 335-347, 2021 10.
Artigo
Inglês
| MEDLINE | ID: mdl-34349026
2.
Discovery and development of CPL207280 as new GPR40/FFA1 agonist.
Eur J Med Chem
; 226: 113810, 2021 Dec 15.
Artigo
Inglês
| MEDLINE | ID: mdl-34537444